Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by lonc17on Mar 06, 2024 10:19am
108 Views
Post# 35917896

RE:RE:Need to clarify & very clear

RE:RE:Need to clarify & very clearI wrote:

"I'm very tired of MC pretending that he is going to finance and run his own P3's."


I can add a few words for clarification, though I thought is was clear enough at the time.

I'm very tired of MC pretending that he is going to finance and run his own P3's without a BP partnership.

I'll say, if ONC has to finance and run its own P3's without a BP partnership then the near term financings will be so incredibly diluting to existing shareholders that we'll have to accept there is no possibility of profiting from this "investment".

Anyone considering an "investment" in ONC at this moment might be well advised to wait till after the capital raise.

Also, I was thinking more about the suggested blackout period and I've concluded it is a very low probablity (less than 5%) that ONC has been in blackout for the past three months. Hence I think it is a very high probability that MC is in non-compliance with Canadian Securities Law. 

All of the above written statments are my opinion only.


<< Previous
Bullboard Posts
Next >>